Magazine Article | February 1, 2021

My Journey From Skepticism To Conviction Regarding AI

Source: Life Science Leader

By Mark Eller

Drug development is a complex, highly regulated practice that relies, most importantly, on experiments and their results.

The initial discovery step relies on human insight to generate hypotheses worth testing in the first experiments. Insights come through knowledge, experience, patience and instinct. Best practices are handed down from researcher to researcher, which in turn helps companies build and refine their hypotheses and grow their pipelines. That has been the traditional path to drug discovery. Another is that computers and artificial intelligence (AI) can replace this traditional model and expedite the entire process. The dichotomy between these two approaches is very real.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader